Lan-ying Gou

Stromal PD-L1–Positive Regulatory T cells and PD-1–Positive CD8-Positive T cells Define the Response of Different Subsets of Non–Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy

Si-Pei Wu, Ri-Qiang Liao, Hai‐Yan Tu et al. · Journal of Thoracic Oncology · 2017 · 153 citations

Life Sciences, Immunology, Oncology +14

DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer

Man Li, Anqi Lin, Peng Luo et al. · Aging · 2020 · 95 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Acquired <i>MET</i> Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non–Small Cell Lung Cancer

Anna Li, Jin‐Ji Yang, Xu‐Chao Zhang et al. · Clinical Cancer Research · 2017 · 91 citations

Medicine, Oncology, Pharmacology +17

Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines

Xiaoyan Bai, Xu‐Chao Zhang, Suqing Yang et al. · PLoS ONE · 2016 · 70 citations · Full text

Medicine, Oncology, Pharmacology +17

The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC

Si‐Yang Maggie Liu, Lan-ying Gou, Anna Li et al. · Journal of Thoracic Oncology · 2016 · 68 citations · Full text

Life Sciences, Genetics, Molecular Genetics +6